These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12099945)

  • 1. Intraoperative hyperthermia and chemoradiotherapy for inoperable pancreatic carcinoma.
    Kouloulias VE; Nikita KS; Kouvaris JR; Golematis BC; Uzunoglu NK; Mystakidou K; Vlahos LJ
    Eur J Cancer Care (Engl); 2002 Jun; 11(2):100-7. PubMed ID: 12099945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoreductive surgery combined with intraoperative chemo-hyperthermia and postoperative radiotherapy in the management of advanced pancreatic adenocarcinoma: feasibility aspects and efficacy.
    Kouloulias VE; Nikita KS; Kouvaris JR; Uzunoglu NK; Golematis VC; Papavasiliou CG; Vlahos LJ
    J Hepatobiliary Pancreat Surg; 2001; 8(6):564-70. PubMed ID: 11956909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraoperative hyperthermia in conjunction with multi-schedule chemotherapy (pre-, intra- and post-operative), by-pass surgery, and post-operative radiotherapy for the management of unresectable pancreatic adenocarcinoma.
    Kouloulias VE; Kouvaris JR; Nikita KS; Golematis BC; Uzunoglu NK; Mystakidou K; Papavasiliou C; Vlahos L
    Int J Hyperthermia; 2002; 18(3):233-52. PubMed ID: 12028639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant intraarterial cisplatin, intravenous 5-flourouracil, and split-course radiation therapy for locally advanced unresectable pancreatic adenocarcinoma: a phase II study of the Puget Sound Oncology Consortium (PSOC-703).
    Thomas CR; Weiden PL; Traverso LW; Thompson T
    Am J Clin Oncol; 1997 Apr; 20(2):161-5. PubMed ID: 9124192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial.
    Snady H; Bruckner H; Cooperman A; Paradiso J; Kiefer L
    Cancer; 2000 Jul; 89(2):314-27. PubMed ID: 10918161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin.
    Kornek GV; Schratter-Sehn A; Marczell A; Depisch D; Karner J; Krauss G; Haider K; Kwasny W; Locker G; Scheithauer W
    Br J Cancer; 2000 Jan; 82(1):98-103. PubMed ID: 10638974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study.
    Al-Sukhun S; Zalupski MM; Ben-Josef E; Vaitkevicius VK; Philip PA; Soulen R; Weaver D; Adsay V; Heilbrun LK; Levin K; Forman JD; Shields AF
    Am J Clin Oncol; 2003 Dec; 26(6):543-9. PubMed ID: 14663369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma.
    Keene KS; Rich TA; Penberthy DR; Shepard RC; Adams R; Jones RS
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):97-103. PubMed ID: 15850908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum.
    Coia L; Hoffman J; Scher R; Weese J; Solin L; Weiner L; Eisenberg B; Paul A; Hanks G
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):161-7. PubMed ID: 8083109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels.
    Abrams RA; Grochow LB; Chakravarthy A; Sohn TA; Zahurak ML; Haulk TL; Ord S; Hruban RH; Lillemoe KD; Pitt HA; Cameron JL; Yeo CJ
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1039-46. PubMed ID: 10421536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant preoperative chemoradiation in patients with pancreatic cancer.
    Magnin V; Moutardier V; Giovannini MH; Lelong B; Giovannini M; Viret F; Monges G; Bardou VJ; Alzieu C; Delpero JR
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1300-4. PubMed ID: 12654441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer: an EORTC GITCCG study.
    Wagener DJ; Hoogenraad WJ; Rougier P; Lusinchi A; Taal BG; Veenhof CH; de Graeff A; Conroy T; Curran D; Sahmoud T; Wils J
    Eur J Cancer; 1996 Jul; 32A(8):1310-3. PubMed ID: 8869091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas.
    White R; Lee C; Anscher M; Gottfried M; Wolff R; Keogan M; Pappas T; Hurwitz H; Tyler D
    Ann Surg Oncol; 1999; 6(1):38-45. PubMed ID: 10030414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: results of a feasibility study.
    André T; Balosso J; Louvet C; Hannoun L; Houry S; Huguier M; Colonna M; Lotz JP; De Gramont A; Bellaïche A; Parc R; Touboul E; Izrael V
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):903-11. PubMed ID: 10705012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of preoperative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: The French SFRO-FFCD 97-04 Phase II trial.
    Mornex F; Girard N; Scoazec JY; Bossard N; Ychou M; Smith D; Seitz JF; Valette PJ; Roy P; Rouanet P; Ducreux M; Partensky C
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1471-8. PubMed ID: 16793214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma -- CapRI: study protocol [ISRCTN62866759].
    Knaebel HP; Märten A; Schmidt J; Hoffmann K; Seiler C; Lindel K; Schmitz-Winnenthal H; Fritz S; Herrmann T; Goldschmidt H; Krempien R; Mansmann U; Debus J; Diehl V; Büchler MW
    BMC Cancer; 2005 Apr; 5():37. PubMed ID: 15826316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.
    Weiner LM; Colarusso P; Goldberg M; Dresler C; Coia LR
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical resection after preoperative chemoradiotherapy benefits selected patients with unresectable pancreatic cancer.
    Aristu J; Cañón R; Pardo F; Martínez-Monge R; Martin-Algarra S; Manuel Ordoñez J; Villafranca E; Moreno M; Cambeiro M; Azinovic I
    Am J Clin Oncol; 2003 Feb; 26(1):30-6. PubMed ID: 12576921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.
    Yeo CJ; Abrams RA; Grochow LB; Sohn TA; Ord SE; Hruban RH; Zahurak ML; Dooley WC; Coleman J; Sauter PK; Pitt HA; Lillemoe KD; Cameron JL
    Ann Surg; 1997 May; 225(5):621-33; discussion 633-6. PubMed ID: 9193189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant radio-chemotherapy in advanced primarilynon-resectable carcinomas of the pancreas.
    Kastl S; Brunner T; Herrmann O; Riepl M; Fietkau R; Grabenbauer G; Sauer R; Hohenberger W; Klein P
    Eur J Surg Oncol; 2000 Sep; 26(6):578-82. PubMed ID: 11034809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.